Creating an Ocular Biofactory: Surgical Approaches in Gene Therapy for Acquired Retinal Diseases. Issue 1 (January 2021)

• Record Type: Journal Article
• Authors: Xu, David; Khan, M. Ali; Ho, Allen C.
• Is Part Of: Asia-Pacific journal of ophthalmology. Volume 10:Issue 1(2021)
• Publication Date: 2021-01
• Subjects: gene therapy, ocular biofactory, retinotomy, suprachoroidal, vitrectomy; Ophthalmology -- Periodicals; Eye -- Diseases -- Periodicals; Periodicals; 617.7005
• DOI: 10.1097/APO.0000000000000362
• Languages: English
• ISSNs: 0129-1653

Abstract

Abstract : Abstract: Gene therapy offers the potential to treat inherited retinal disorders and deliver sustained therapy for acquired retinal diseases. In the latter case, host cells can be harnessed to produce non-native proteins that have beneficial properties, such as antivascular endothelial growth factor activity, transforming the eye into an ocular "biofactory." Several gene therapy programs have entered clinical testing for delivery to the vitreous, subretinal, and suprachoroidal space. Improved viral vectors and refined surgical techniques are critical to successful delivery of therapeutic products to the target tissue. In this review, we discuss the development of gene therapy products aimed at acquired retinal diseases and the surgical techniques utilized to achieve targeted delivery.